Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose

Venezuelan equine encephalitis virus (VEEV) is a re-emerging virus of human, agriculture, and bioweapon threat importance. No FDA-approved treatment is available to combat Venezuelan equine encephalitis in humans, prompting the need to create a vaccine that is safe, efficacious, and cannot be replic...

Full description

Bibliographic Details
Main Authors: Shannan L. Rossi, Kasi E. Russell-Lodrigue, Kenneth S. Plante, Nicholas A. Bergren, Rodion Gorchakov, Chad J. Roy, Scott C. Weaver
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/3/497
_version_ 1827707050049667072
author Shannan L. Rossi
Kasi E. Russell-Lodrigue
Kenneth S. Plante
Nicholas A. Bergren
Rodion Gorchakov
Chad J. Roy
Scott C. Weaver
author_facet Shannan L. Rossi
Kasi E. Russell-Lodrigue
Kenneth S. Plante
Nicholas A. Bergren
Rodion Gorchakov
Chad J. Roy
Scott C. Weaver
author_sort Shannan L. Rossi
collection DOAJ
description Venezuelan equine encephalitis virus (VEEV) is a re-emerging virus of human, agriculture, and bioweapon threat importance. No FDA-approved treatment is available to combat Venezuelan equine encephalitis in humans, prompting the need to create a vaccine that is safe, efficacious, and cannot be replicated in the mosquito vector. Here we describe the use of a serotype ID VEEV (ZPC-738) vaccine with an internal ribosome entry site (IRES) to alter gene expression patterns. This ZPC/IRES vaccine was genetically engineered in two ways based on the position of the IRES insertion to create a vaccine that is safe and efficacious. After a single dose, both versions of the ZPC/IRES vaccine elicited neutralizing antibody responses in mice and non-human primates after a single dose, with more robust responses produced by version 2. Further, all mice and primates were protected from viremia following VEEV challenge. These vaccines were also safer in neonatal mice than the current investigational new drug vaccine, TC-83. These results show that IRES-based attenuation of alphavirus genomes consistently produce promising vaccine candidates, with VEEV/IRES version 2 showing promise for further development.
first_indexed 2024-03-10T16:38:09Z
format Article
id doaj.art-c0046c07980d447fb988bbbc01ca40f1
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T16:38:09Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-c0046c07980d447fb988bbbc01ca40f12023-11-20T12:16:43ZengMDPI AGVaccines2076-393X2020-09-018349710.3390/vaccines8030497Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single DoseShannan L. Rossi0Kasi E. Russell-Lodrigue1Kenneth S. Plante2Nicholas A. Bergren3Rodion Gorchakov4Chad J. Roy5Scott C. Weaver6Department of Pathology and Microbiology and Immunology, Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USATulane National Primate Research Center, Covington, LA 70433, USADepartment of Microbiology and Immunology and World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Health, Safety and Environment, King Abdullah University of Science and Technology, Thuwal 23955, Saudi ArabiaTulane National Primate Research Center, Covington, LA 70433, USAWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX 77555, USAVenezuelan equine encephalitis virus (VEEV) is a re-emerging virus of human, agriculture, and bioweapon threat importance. No FDA-approved treatment is available to combat Venezuelan equine encephalitis in humans, prompting the need to create a vaccine that is safe, efficacious, and cannot be replicated in the mosquito vector. Here we describe the use of a serotype ID VEEV (ZPC-738) vaccine with an internal ribosome entry site (IRES) to alter gene expression patterns. This ZPC/IRES vaccine was genetically engineered in two ways based on the position of the IRES insertion to create a vaccine that is safe and efficacious. After a single dose, both versions of the ZPC/IRES vaccine elicited neutralizing antibody responses in mice and non-human primates after a single dose, with more robust responses produced by version 2. Further, all mice and primates were protected from viremia following VEEV challenge. These vaccines were also safer in neonatal mice than the current investigational new drug vaccine, TC-83. These results show that IRES-based attenuation of alphavirus genomes consistently produce promising vaccine candidates, with VEEV/IRES version 2 showing promise for further development.https://www.mdpi.com/2076-393X/8/3/497Venezuelan equine encephalitis virusvaccineinternal ribosome entry siteprimates
spellingShingle Shannan L. Rossi
Kasi E. Russell-Lodrigue
Kenneth S. Plante
Nicholas A. Bergren
Rodion Gorchakov
Chad J. Roy
Scott C. Weaver
Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
Vaccines
Venezuelan equine encephalitis virus
vaccine
internal ribosome entry site
primates
title Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
title_full Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
title_fullStr Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
title_full_unstemmed Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
title_short Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
title_sort rationally attenuated vaccines for venezuelan equine encephalitis protect against epidemic strains with a single dose
topic Venezuelan equine encephalitis virus
vaccine
internal ribosome entry site
primates
url https://www.mdpi.com/2076-393X/8/3/497
work_keys_str_mv AT shannanlrossi rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT kasierusselllodrigue rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT kennethsplante rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT nicholasabergren rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT rodiongorchakov rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT chadjroy rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose
AT scottcweaver rationallyattenuatedvaccinesforvenezuelanequineencephalitisprotectagainstepidemicstrainswithasingledose